Culture Test for Healthcare-associated Infections: Revolution in Europe and MEA

Understanding the Basics of Healthcare-Associated Infections
By: TMR
 
PUNE, India - Jan. 22, 2025 - PRLog -- Healthcare-associated infections (HAIs) are a persistent global challenge, particularly in regions such as Europe and the Middle East & Africa (MEA). These infections, contracted during medical care in hospitals, clinics, and long-term care facilities, place a significant burden on patients and healthcare systems alike.

Understanding Culture Tests and Their Role in Combating HAIs

Culture tests are the gold standard for diagnosing HAIs. These tests involve growing microorganisms from clinical samples to identify the type and characteristics of pathogens causing infections. The process enables healthcare professionals to determine the antibiotic susceptibility of the pathogens, which is essential for selecting the most effective treatment. Products in this space include instruments, reagents, and consumables, which together form an indispensable arsenal for diagnosing and managing infections. With the increasing prevalence of antibiotic-resistant bacteria, the role of culture tests has become even more vital, ensuring that infections are identified and treated accurately and efficiently.

Key Test Types: Addressing a Spectrum of Infections

Culture tests are tailored to diagnose a wide range of HAIs caused by various pathogens. Among the most common tests are those targeting Escherichia coli, a primary cause of urinary tract infections and bloodstream infections. Similarly, Staphylococcus aureus, including its methicillin-resistant variant (MRSA), is a frequent culprit in surgical site infections and other HAIs, necessitating robust diagnostic methods. Enterococcus species, known for their multidrug resistance, often cause bloodstream and urinary infections, further highlighting the need for precise testing.

The Europe and Middle East & Africa (MEA) culture test market (https://www.transparencymarketresearch.com/europe-mea-hea...) for healthcare-associated infections was valued at USD 270.3 million in 2023 and is poised for steady growth. With a projected compound annual growth rate (CAGR) of 2.9% from 2024 to 2034, the market is anticipated to exceed USD 371.3 million by 2034. This growth is driven by increasing awareness of infection control, rising prevalence of multidrug-resistant organisms, and advancements in diagnostic technologies across the regions.

Contact
Ajay Mhatale
***@halbov.com
End
Source:TMR
Email:***@halbov.com Email Verified
Tags:CultureTests
Industry:Health
Location:Pune - Maharashtra - India
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse



Like PRLog?
9K2K1K
Click to Share